# Effect of Probiotics "Psychobiotics" on Depression and Metabolic Syndrome in Saudi Arabia

> **NCT06765057** · PHASE2,PHASE3 · RECRUITING · sponsor: **Roaa Ahmed Alkreadees** · enrollment: 60 (estimated)

## Conditions studied

- Depression Anxiety Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Winclove's Ecologic® Barrier Probiotics
- **DIETARY_SUPPLEMENT:** Winclove's Ecologic® Barrier Probiotics Placebo

## Key facts

- **NCT ID:** NCT06765057
- **Lead sponsor:** Roaa Ahmed Alkreadees
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-02
- **Primary completion:** 2026-02-28
- **Final completion:** 2027-01-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06765057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06765057, "Effect of Probiotics "Psychobiotics" on Depression and Metabolic Syndrome in Saudi Arabia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06765057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*